$TYRA

$21.52 +$1.10 (5.39%) Close

$TYRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$TYRA Management Team

Ms. Amy Conrad

Investor Relations

Age -

Compensation -

Sex Female

Mr. Robert More

Independent Chairman of the Board

Age 57

Compensation $305.7K USD

Sex Male

Dr. Todd Harris

President

Chief Executive Officer

Treasurer

Director

Age 45

Compensation $7.570M USD

Sex Male

Mr. Alan Fuhrman

Chief Financial Officer

Age 68

Compensation $3.531M USD

Sex Male

Mr. Daniel Bensen

Chief Discovery Officer

Age 50

Compensation $2.655M USD

Sex Male

Dr. Douglas Warner

Chief Medical Officer

Age 53

Compensation $4.726M USD

Sex Male

Mr. Bhavesh Ashar

Chief Operating Officer

Age 60

Compensation -

Sex Male

Ms. Heather Faulds

Chief Regulatory Officer

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Ms. Amy Conrad Investor Relations	-	-	Female
Mr. Robert More Independent Chairman of the Board	57	$305.7K USD	Male
Dr. Todd Harris President Chief Executive Officer Treasurer Director	45	$7.570M USD	Male
Mr. Alan Fuhrman Chief Financial Officer	68	$3.531M USD	Male
Mr. Daniel Bensen Chief Discovery Officer	50	$2.655M USD	Male
Dr. Douglas Warner Chief Medical Officer	53	$4.726M USD	Male
Mr. Bhavesh Ashar Chief Operating Officer	60	-	Male
Ms. Heather Faulds Chief Regulatory Officer	-	-	Female

Board of Directors

From the proxy statement filed Apr 17, 2026

Directors

serving now

Independent

9 of 10

stated in the proxy

Average tenure

4.1 years

from year joined

CEO also chairs the board

Robert More

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Habib J. Dable	56	2026 0 years	Independent	None stated	Spyglass Pharma, Inc.	Not stated
Susan Moran, M.D., M.S.C.E.	56	2024 2 years	Independent	Compensation · Chair Science and Technology	None stated	$203,272
Robert More Board chair	58	2018 8 years	Independent	Audit Nominating and Corporate Governance · Chair	Vir Biotechnology, Inc.	$232,670
Melissa McCracken, Ph.D.	39	2021 5 years	Independent	Audit Science and Technology	Alterome Therapeutics, Inc., Airna, Inc., Ambagon Therapeutics, Inc., Alpha-9 Oncology, K36 Therapeutics, Inc.	Not stated
Jake Simson, Ph.D.	40	2020 6 years	Independent	Nominating and Corporate Governance Science and Technology · Chair	Janux Therapeutics, Inc.	$203,535
Rehan Verjee	45	2021 5 years	Independent	Audit · Chair Compensation	None stated	$205,570
Todd Harris, Ph.D. CEO	46	2018 8 years	Not independent	None stated	None stated	Paid as CEO
Adele M. Gulfo	63	2025 1 year	Independent	Compensation	New Amsterdam Pharma Co N.V., Enpro Inc.	$553,721
S. Michael Rothenberg, M.D., Ph.D.	56	2024 2 years	Independent	Science and Technology	None stated	$192,465
Gilla Kaplan, Ph.D. Leaving at the meeting	Not stated	Not stated	Independent	Nominating and Corporate Governance Science and Technology	None stated	$197,057

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 17, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$TYRA Management Team

Ms. Amy Conrad

Mr. Robert More

Dr. Todd Harris

Mr. Alan Fuhrman

Mr. Daniel Bensen

Dr. Douglas Warner

Mr. Bhavesh Ashar

Ms. Heather Faulds

Board of Directors

Related-party transactions

No related-party transactions disclosed